Stacie Canan-Koch

Title: The Innovation Journey of Stacie Canan-Koch: Pioneering Dimer-Selective RXR Modulators

Introduction:

Stacie Canan-Koch, a brilliant inventor based in San Diego, CA, has made a significant impact in the pharmaceutical field with his groundbreaking work on dimer-selective RXR modulators. His innovative spirit and dedication have led to the development of novel compounds with versatile activity in various genetic contexts.

Latest Patents:

Stacie Canan-Koch holds a patent for "Dimer-selective RXR modulators and methods for their use," showcasing his expertise in the design and application of compounds that modulate RXR homodimers and heterodimers. This patent underscores his commitment to advancing therapeutic options through targeted pharmaceutical compositions.

Career Highlights:

Currently employed at Ligand Pharmaceuticals, Inc., Stacie Canan-Koch continues to spearhead research and development initiatives in the pharmaceutical industry. His role at Ligand Pharmaceuticals, Inc. allows him to leverage his skills and knowledge to drive innovation and bring transformative solutions to market.

Collaborations:

Stacie Canan-Koch collaborates closely with esteemed coworkers Chan Kou Hwang and Marcus F. Boehm, fostering a dynamic environment where ideas flourish and innovative concepts come to life. Together, they form a formidable team that is dedicated to pushing the boundaries of pharmaceutical research and development.

Conclusion:

In conclusion, Stacie Canan-Koch stands out as a pioneering inventor in the realm of dimer-selective RXR modulators. His patents, career highlights at Ligand Pharmaceuticals, Inc., and collaborations with esteemed colleagues like Chan Kou Hwang and Marcus F. Boehm underscore his significant contributions to the field of pharmaceutical innovation. Stacie Canan-Koch's work continues to inspire and shape the future of therapeutic interventions, making him a prominent figure in the world of pharmaceutical research.